(Q35976422)

11 August 2017

1 reference

title

Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

4

Borivoj Vojtesek

1 reference

11 August 2017

Dalibor Valik

1

1 reference

11 August 2017

Martin Radina

series ordinal

2

1 reference

11 August 2017

Jaroslav Sterba

series ordinal

3

1 reference

11 August 2017

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

8

1 reference

11 August 2017

page(s)

1151-1162

1 reference

Facts and recommendations about total homocysteine determinations: an expert opinion

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Multicenter analytical evaluation of an enzymatic method for the measurement of plasma homocysteine and comparison with HPLC and immunochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Molecular basis of homocysteine toxicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Resistance to antifolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Medical approaches and future options in chronic active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Mechanisms of action of methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

The pharmacology and clinical use of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Methotrexate-induced apoptosis in hepatocytes after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Optimal management of methotrexate intoxication in a child with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Biochemical and Clinical Aspects of Methotrexate Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Aminophylline for methotrexate-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Pteridines and mono-amines: relevance to neurological damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Stroke-like syndrome, mineralizing microangiopathy, and neuroaxonal dystrophy following intrathecal methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Elevated levels of plasma homocysteine are associated with neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Cancer pharmacogenetics: polymorphisms, pathways and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

Microarray reality checks in the context of a complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.8.1151

10.1517/14622416.5.8.1151

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference